Stock Groups

China’s Beijing orders more COVID tests as cases mount before Olympics -Breaking

[ad_1]

© Reuters. Following the outbreak of coronavirus (COVID-19), in Beijing, China on January 17, 2022, people gathered to undergo nucleic acid testing at an outside hospital. REUTERS/Carlos Garcia Rawlins

BEIJING (Reuters – More COVID-19 test orders were issued by the Chinese government’s capital on Sunday. The city reported more local cases less than two months before the Winter Olympic Games.

On Jan. 22, nine locally transmitted patients with confirmed symptoms were discovered in Beijing, compared to 10 the day before, according to the National Health Commission. Six of these cases were located in Beijing’s Fengtai District.

According to district health officials, Fengtai plans to organise COVID-19 testing nucleic acids for all its residents on Sunday.

Beijing also requested residents to perform proactive nucleic acids tests in the event of COVID-19 symptoms, local authorities stated in a Saturday statement.

China has urged its citizens to protect their mail by wearing gloves and masks, particularly if it comes from outside. This was after Canadian authorities indicated that the Omicron version of coronavirus could have reached Beijing via Canada.

China’s cities have taken tougher measures in recent weeks to combat new COVID-19 epidemics. The task is more pressing as Beijing gets ready to host the Winter Olympics starting next month.

Many cities require residents to either stay where they are or to inform travellers days prior to their arrival.

56 cases of COVID-19 were reported in Mainland China by the national health authority on Jan. 22. That’s down from 63 cases a single day earlier.

According to the National Health Commission, 19 new cases of malaria were localized, compared with 23 days earlier. The rest was imported.

From 43 cases a day prior, China saw 34 new cases of asymptomatic disease.

No new deaths were reported, leaving 4,636 dead.

As of January 22, China had confirmed the existence of 105,603 new cases.

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]